{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T22:17:49Z","timestamp":1767046669800},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH","award":["HL-78825","R01HL147921, P30GM127607"],"award-info":[{"award-number":["HL-78825","R01HL147921, P30GM127607"]}]},{"name":"AHA","award":["16SDG29950012"],"award-info":[{"award-number":["16SDG29950012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11010-022-04590-2","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T13:02:45Z","timestamp":1666702965000},"page":"1245-1250","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Transient gene therapy using cell cycle factors reverses renin\u2013angiotensin\u2013aldosterone system activation in heart failure rat model"],"prefix":"10.1007","volume":"478","author":[{"given":"Abou Bakr M.","family":"Salama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riham R. E.","family":"Abouleisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghui","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Liang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nashwah","family":"Alhariry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Gebreil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzammil","family":"Dastagir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fareeha","family":"Abdulwali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Bolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer M. A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"issue":"10","key":"4590_CR1","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1161\/01.RES.0000020201.44772.67","volume":"90","author":"KBS Pasumarthi","year":"2002","unstructured":"Pasumarthi KBS, Field LJ (2002) Cardiomyocyte cell cycle regulation. Circ Res 90(10):1044\u20131054. https:\/\/doi.org\/10.1161\/01.RES.0000020201.44772.67","journal-title":"Circ Res"},{"issue":"20","key":"4590_CR2","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","volume":"138","author":"K Thygesen","year":"2018","unstructured":"Thygesen K et al (2018) Fourth universal definition of myocardial infarction. Circulation 138(20):e618\u2013e651. https:\/\/doi.org\/10.1161\/CIR.0000000000000617","journal-title":"Circulation"},{"issue":"2","key":"4590_CR3","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1016\/0002-9149(85)91199-3","volume":"56","author":"WW Parmley","year":"1985","unstructured":"Parmley WW (1985) Pathophysiology of congestive heart failure. Am J Cardiol 56(2):A7\u2013A11. https:\/\/doi.org\/10.1016\/0002-9149(85)91199-3","journal-title":"Am J Cardiol"},{"issue":"Suppl 1","key":"4590_CR4","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.3317\/jraas.2004.024","volume":"5","author":"T Unger","year":"2004","unstructured":"Unger T, Li J (2004) The role of the renin-angiotensin-aldosterone system in heart failure. J Renin Angiotensin Aldosterone Syst 5(Suppl 1):S7-10. https:\/\/doi.org\/10.3317\/jraas.2004.024","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"4590_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147720","author":"ABM Salama","year":"2021","unstructured":"Salama ABM, Gebreil A, Mohamed TMA, Abouleisa RRE (2021) Induced cardiomyocyte proliferation: a promising approach to cure heart failure. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22147720","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4590_CR6","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/cvr\/cvab135","volume":"118","author":"R Bolli","year":"2022","unstructured":"Bolli R, Solankhi M, Tang XL, Kahlon A (2022) Cell therapy in patients with heart failure: a comprehensive review and emerging concepts. Cardiovasc Res 118(4):951\u2013976. https:\/\/doi.org\/10.1093\/cvr\/cvab135","journal-title":"Cardiovasc Res"},{"issue":"1","key":"4590_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cell.2018.02.014","volume":"173","author":"TMA Mohamed","year":"2018","unstructured":"Mohamed TMA et al (2018) Regulation of cell cycle to stimulate adult cardiomyocyte proliferation and cardiac regeneration. Cell 173(1):104-116.e12. https:\/\/doi.org\/10.1016\/j.cell.2018.02.014","journal-title":"Cell"},{"key":"4590_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.121.057641","author":"RRE Abouleisa","year":"2022","unstructured":"Abouleisa RRE et al (2022) Transient cell cycle induction in cardiomyocytes to treat subacute ischemic heart failure. Circulation. https:\/\/doi.org\/10.1161\/circulationaha.121.057641","journal-title":"Circulation"},{"issue":"22","key":"4590_CR9","doi-asserted-by":"publisher","first-page":"e1054","DOI":"10.1161\/CIR.0000000000000490","volume":"135","author":"SL Chow","year":"2017","unstructured":"Chow SL et al (2017) Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American heart association. Circulation 135(22):e1054\u2013e1091. https:\/\/doi.org\/10.1161\/CIR.0000000000000490","journal-title":"Circulation"},{"issue":"10","key":"4590_CR10","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/eurheartj\/ehq019","volume":"31","author":"A Tomaschitz","year":"2010","unstructured":"Tomaschitz A, Pilz S, Ritz E, Meinitzer A, Boehm BO, M\u00e4rz W (2010) Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Eur Heart J 31(10):1237\u20131247. https:\/\/doi.org\/10.1093\/eurheartj\/ehq019","journal-title":"Eur Heart J"},{"issue":"10","key":"4590_CR11","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/clinchem\/37.10.1811","volume":"37","author":"JE Sealey","year":"1991","unstructured":"Sealey JE (1991) Plasma renin activity and plasma prorenin assays. Clin Chem 37(10):1811\u20131819. https:\/\/doi.org\/10.1093\/clinchem\/37.10.1811","journal-title":"Clin Chem"},{"issue":"11","key":"4590_CR12","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1373\/clinchem.2004.033654","volume":"50","author":"D Hartman","year":"2004","unstructured":"Hartman D, Sagnella GA, Chesters CA, MacGregor GA (2004) Direct renin assay and plasma renin activity assay compared. Clin Chem 50(11):2159\u20132161. https:\/\/doi.org\/10.1373\/clinchem.2004.033654","journal-title":"Clin Chem"},{"issue":"1","key":"4590_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","volume":"14","author":"J Hartupee","year":"2017","unstructured":"Hartupee J, Mann DL (2017) Neurohormonal activation in heart failure with reduced ejection fraction. Nat Rev Cardiol 14(1):30\u201338. https:\/\/doi.org\/10.1038\/nrcardio.2016.163","journal-title":"Nat Rev Cardiol"},{"issue":"15","key":"4590_CR14","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1136\/heartjnl-2018-314173","volume":"105","author":"K Salah","year":"2019","unstructured":"Salah K et al (2019) Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction. Heart 105(15):1182. https:\/\/doi.org\/10.1136\/heartjnl-2018-314173","journal-title":"Heart"},{"issue":"6","key":"4590_CR15","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/cir.0000000000000509","volume":"136","author":"CW Yancy","year":"2017","unstructured":"Yancy CW et al (2017) 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American heart association task force on clinical practice guidelines and the heart failure society of America. Circulation 136(6):e137\u2013e161. https:\/\/doi.org\/10.1161\/cir.0000000000000509","journal-title":"Circulation"},{"key":"4590_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.12.012","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA et al (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.012","journal-title":"J Am Coll Cardiol"},{"key":"4590_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2013.09.002","author":"G Sayer","year":"2014","unstructured":"Sayer G, Bhat G (2014) The renin-angiotensin-aldosterone system and heart failure. Cardiol Clin. https:\/\/doi.org\/10.1016\/j.ccl.2013.09.002","journal-title":"Cardiol Clin"},{"issue":"3","key":"4590_CR18","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.118.11065","volume":"72","author":"G Jia","year":"2018","unstructured":"Jia G, Aroor AR, Hill MA, Sowers JR (2018) Role of renin-angiotensin-aldosterone system activation in promoting cardiovascular fibrosis and stiffness. Hypertension 72(3):537\u2013548. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.118.11065","journal-title":"Hypertension"},{"key":"4590_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.21037\/arh.2019.05.01","volume":"3","author":"C Bakogiannis","year":"2019","unstructured":"Bakogiannis C et al (2019) A translational approach to the renin-angiotensin-aldosterone system in heart failure. Ann Res Hosp 3:11","journal-title":"Ann Res Hosp"},{"issue":"3","key":"4590_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrcardio.2011.172","volume":"9","author":"N Koitabashi","year":"2012","unstructured":"Koitabashi N, Kass DA (2012) Reverse remodeling in heart failure\u2014mechanisms and therapeutic opportunities. Nat Rev Cardiol 9(3):147\u2013157. https:\/\/doi.org\/10.1038\/nrcardio.2011.172","journal-title":"Nat Rev Cardiol"},{"key":"4590_CR21","doi-asserted-by":"publisher","DOI":"10.5935\/abc.20150025","author":"JRDAR Reis Filho","year":"2015","unstructured":"Reis Filho JRDAR, Cardoso JN, Cardoso CMDR, Pereira-Barretto AC (2015) Reverse cardiac remodeling: a marker of better prognosis in heart failure. Arq Bras Cardiol. https:\/\/doi.org\/10.5935\/abc.20150025","journal-title":"Arq Bras Cardiol"},{"issue":"2","key":"4590_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.numecd.2008.03.001","volume":"19","author":"MK Hagen","year":"2009","unstructured":"Hagen MK et al (2009) Diet with isolated soy protein reduces oxidative stress and preserves ventricular function in rats with myocardial infarction. Nutr Metab Cardiovasc Dis 19(2):91\u201397. https:\/\/doi.org\/10.1016\/j.numecd.2008.03.001","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"4590_CR23","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1590\/s0066-782x2009001000018","volume":"93","author":"LAM Zornoff","year":"2009","unstructured":"Zornoff LAM, Paiva SAR, Minicucci MF, Spadaro J (2009) Infarto do mioc\u00e1rdio experimental em ratos: an\u00e1lise do modelo. Arq Bras Cardiol 93(4):434\u2013440. https:\/\/doi.org\/10.1590\/s0066-782x2009001000018","journal-title":"Arq Bras Cardiol"},{"issue":"3","key":"4590_CR24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10741-018-9762-4","volume":"24","author":"J Cops","year":"2019","unstructured":"Cops J, Haesen S, De Moor B, Mullens W, Hansen D (2019) Current animal models for the study of congestion in heart failure: an overview. Heart Fail Rev 24(3):387\u2013397. https:\/\/doi.org\/10.1007\/s10741-018-9762-4","journal-title":"Heart Fail Rev"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04590-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-022-04590-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04590-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T18:03:21Z","timestamp":1683396201000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-022-04590-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["4590"],"URL":"https:\/\/doi.org\/10.1007\/s11010-022-04590-2","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,25]]},"assertion":[{"value":"12 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TMAM holds equities in Tenaya Therapeutics. The other authors report no conflict.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No animal studies were carried out by the authors for this article. Plasma and tissue samples were available from previous studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animals rights"}}]}}